Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
JAMA
|
June 8, 2023
Congress' Misguided Plan to Ban QALYs
Leah Z Rand, Adam Raymakers, Benjamin N Rome
AMA Journal of Ethics
|
November 7, 2022
What Should US Policymakers Learn From International Drug Pricing Transparency Strategies?
Sarosh Nagar, Leah Z Rand, Aaron S Kesselheim
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 7, 2026
Conflicts of Interest in FDA Advisory Committees: A Systematic Literature Review
Arianna Gentilini, Adam J N Raymakers, Leah Z Rand
The American Journal of Bioethics : AJOB
|
July 30, 2025
The Limits of Physician-Level Interventions for Cost-Related Nonadherence: A Case for Structural Reform
Daniel Eisenkraft Klein, Aaron S Kesselheim, Leah Z Rand
Health Services Research
|
December 20, 2022
Alternatives to the quality-adjusted life year: How well do they address common criticisms?
Leah Z Rand, G J Melendez-Torres, Aaron S Kesselheim
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 4, 2024
The Value of the Quality-Adjusted Life Years
Richard J Willke, Laura T Pizzi, Leah Z Rand, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
July 27, 2022
High-Priced Sickle Cell Gene Therapies Threaten to Exacerbate US Health Disparities and Establish New Pricing Precedents for Molecular Medicine
Frazer A Tessema, Ameet Sarpatwari, Leah Z Rand, et al.
Journal of Cancer Policy
|
February 2, 2025
An empirical investigation into concerns over quality-adjusted life-years: A review of cost-effectiveness analyses in oncology
Adam J N Raymakers, Leah Z Rand, William B Feldman, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
July 6, 2025
Impostor Syndrome: Fraudulent Participants in Qualitative Research Can Skew Results
Leah Z Rand, Sarah McGraw, Junyi Wang, et al.
Health Affairs (Project Hope)
|
August 4, 2025
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations
Daniel A Ollendorf, Leah Z Rand, Alessandra Blonda, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
JAMA
|
June 8, 2023
Congress' Misguided Plan to Ban QALYs
Leah Z Rand, Adam Raymakers, Benjamin N Rome
AMA Journal of Ethics
|
November 7, 2022
What Should US Policymakers Learn From International Drug Pricing Transparency Strategies?
Sarosh Nagar, Leah Z Rand, Aaron S Kesselheim
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 7, 2026
Conflicts of Interest in FDA Advisory Committees: A Systematic Literature Review
Arianna Gentilini, Adam J N Raymakers, Leah Z Rand
The American Journal of Bioethics : AJOB
|
July 30, 2025
The Limits of Physician-Level Interventions for Cost-Related Nonadherence: A Case for Structural Reform
Daniel Eisenkraft Klein, Aaron S Kesselheim, Leah Z Rand
Health Services Research
|
December 20, 2022
Alternatives to the quality-adjusted life year: How well do they address common criticisms?
Leah Z Rand, G J Melendez-Torres, Aaron S Kesselheim
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 4, 2024
The Value of the Quality-Adjusted Life Years
Richard J Willke, Laura T Pizzi, Leah Z Rand, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
July 27, 2022
High-Priced Sickle Cell Gene Therapies Threaten to Exacerbate US Health Disparities and Establish New Pricing Precedents for Molecular Medicine
Frazer A Tessema, Ameet Sarpatwari, Leah Z Rand, et al.
Journal of Cancer Policy
|
February 2, 2025
An empirical investigation into concerns over quality-adjusted life-years: A review of cost-effectiveness analyses in oncology
Adam J N Raymakers, Leah Z Rand, William B Feldman, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
July 6, 2025
Impostor Syndrome: Fraudulent Participants in Qualitative Research Can Skew Results
Leah Z Rand, Sarah McGraw, Junyi Wang, et al.
Health Affairs (Project Hope)
|
August 4, 2025
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations
Daniel A Ollendorf, Leah Z Rand, Alessandra Blonda, et al.
Page
of 3